首页> 外国专利> 'synthesis of novel biologically active mixed ligand yttrium(iii) complexes'

'synthesis of novel biologically active mixed ligand yttrium(iii) complexes'

机译:“新型生物活性混合配体钇(iii)配合物的合成”

摘要

Present invention reports synthesis of biologically active mixed ligand Yttrium(III) complexes from Yttrium(III) chloride, 8-hydroxyquinoline (HQ) and N and / or O donor amino acids (HL) such as L-threonine, L-proline, L-hydroxyproline, L-isoleucine and L-serine. The method comprises conversion of Yttrium(III) chloride precursors to desired complexes using 8-hydroxyquinoline (HQ) as primary ligand (HQ) and amino acids (HL) as secondary ligands (HL) in 1:2:1 proportion. The synthesized mixed ligand Yttrium(III) complexes are novel as they are reported first time. The prepared complexes show excellent biological and germination activity.
机译:本发明报道了由氯化钇(III),8-羟基喹啉(HQ)和N和/或O供体氨基酸(HL)例如L-苏氨酸,L-脯氨酸,L合成具有生物活性的混合配体钇(III)复合物。 -羟脯氨酸,L-异亮氨酸和L-丝氨酸。该方法包括使用8-羟基喹啉(HQ)作为主要配体(HQ)和氨基酸(HL)作为次要配体(HL)以1:2:1的比例将氯化钇(III)前体转化为所需的络合物。合成的混合配体钇(III)配合物是新颖的,因为它们是首次报道。制备的复合物显示出优异的生物学和发芽活性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号